Vision Care Market

The secondary research process involved comprehensive analysis of regulatory databases for ophthalmic devices and vision care products, peer-reviewed ophthalmology and optometry journals, clinical publications, and authoritative vision health organizations. Key sources included the US Food & Drug Administration (FDA) Center for Devices and Radiological Health (ophthalmic devices), European Medicines Agency (EMA), Health Canada Medical Devices Bureau, International Council of Ophthalmology (ICO), American Academy of Ophthalmology (AAO), American Optometric Association (AOA), National Institutes of Health (NIH) National Eye Institute (NEI), Centers for Disease Control and Prevention (CDC) Vision Health Initiative, World Health Organization (WHO) Global Health Observatory and Vision 2020 program, EU Eurostat Health Database, International Agency for the Prevention of Blindness (IAPB), National Health Service (NHS) England Eye Health Statistics, Japan Ophthalmologists Association reports, and national health ministry reports from key markets including China National Health Commission and India's Ministry of Health & Family Welfare. These sources were used to collect vision impairment prevalence statistics, myopia progression data, regulatory approval data for contact lenses and intraocular lenses, clinical safety studies on refractive surgeries, demographic aging trends affecting presbyopia rates, optical retail landscape analysis, and reimbursement policies for vision correction procedures.

To gather both qualitative and quantitative information, the primary research process involved interviewing players from both the supply and demand sides. Eyeglasses, contact lenses, intraocular lenses, ophthalmic pharmaceuticals, and optical retail chains' chief executive officers, managing directors, VPs of product development, heads of professional affairs, and commercial directors were among the supply-side sources. On the demand side, we have medical directors of vision care clinics, optometrists, refractive surgeons, ophthalmologists with board certifications, owners and purchasers of optical stores, procurement leads from eye hospitals and ambulatory surgery centers, and others. The following points were derived from primary sources: product pipeline timelines for extended depth of focus IOLs and myopia control lenses, market segmentation for spectacles, contact lenses, and surgical vision correction; clinical adoption patterns of laser vision correction; pricing strategies for premium toric and multifocal lenses; reimbursement dynamics for cataract surgery and optical dispensing; and insights into these topics.

Primary Respondent Breakdown:

By Designation: C-level Primaries (32%), Director Level (30%), Others (38%)

By Region: North America (32%), Europe (30%), Asia-Pacific (28%), Rest of World (10%)

Global market valuation was derived through revenue mapping, unit volume analysis, and procedure volume assessment. The methodology included:

Identification of 45+ key manufacturers across North America, Europe, Asia-Pacific, and Latin America specializing in eyeglasses, contact lenses, intraocular lenses, lens care solutions, and ophthalmic pharmaceuticals

Product mapping across soft contact lenses (spherical, toric, multifocal), rigid gas permeable lenses, myopia control devices, premium intraocular lenses (monofocal, multifocal, toric, EDOF), spectacle lenses (single vision, progressive, photochromic), and over-the-counter eye drops

Analysis of reported and modeled annual revenues specific to vision care portfolios of diversified healthcare conglomerates and pure-play eyewear companies

Coverage of manufacturers representing 70-75% of global market share in 2024, including comprehensive data from EssilorLuxottica, Johnson & Johnson Vision, Alcon, Bausch + Lomb, The Cooper Companies, Carl Zeiss Meditec, HOYA Corporation, and Menicon

Extrapolation using bottom-up (contact lens fits × ASP, spectacle unit sales × lens pricing, cataract procedures × IOL ASP by country) and top-down (manufacturer revenue validation and optical retail channel checks) approaches to derive segment-specific valuations for refractive correction, surgical vision care, and contact lens solutions